28 March 2017
WITHDRAWING FENTANYL IS A ‘STEP BACK’ FOR DYING CANCER PATIENTS NEEDING URGENT PAIN RELIEF, WARNS MACMILLAN
Responding to the possible withdrawal of Fentanyl from the NHS prescription list, Dr Rosie Loftus, Chief Medical Officer at Macmillan Cancer Support, says:
“It’s very disappointing to hear that Fentanyl is on the list of items being considered for withdrawal from NHS prescriptions. It is a drug often given to cancer patients to provide crucial pain relief at the end of their life. This move would signal a step back in how we manage people’s care when they’re dying.
“The last few days, weeks or months of someone’s life are precious and everyone deserves to have the best possible quality of life, free from pain.
“We understand the financial pressure the NHS is under, but for some patients it might be the only or best medication that can help ease discomfort in their final days.”
For further information, please contact:
Jess Owen, Media & PR Officer, Macmillan Cancer Support
0207 0912407 (out of hours 07801 307068)
Notes to Editors:
About Macmillan Cancer Support
When you have cancer, you don’t just worry about what will happen to your body, you worry about what will happen to your life. Whether it’s concerns about who you can talk to, planning for the extra costs or what to do about work, at Macmillan we understand how a cancer diagnosis can take over everything.
That’s why we’re here. We provide support that helps people take back control of their lives. But right now, we can’t reach everyone who needs us. We need your help to make sure that people affected by cancer get the support they need to face the toughest fight of their life. No one should face cancer alone, and with your support no one will.
To get involved, call 0300 1000 200 today. And please remember, we’re here for you too. If you’d like support, information or just to chat, call us free on 0808 808 00 00 (Monday to Friday, 9am–8pm) or visit macmillan.org.uk